Abound Wealth Management Sarepta Therapeutics, Inc. Transaction History
Abound Wealth Management
- $427 Billion
- Q4 2025
A detailed history of Abound Wealth Management transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 6 shares of SRPT stock, worth $112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
408Shares Held
83.4MCall Options Held
5.27MPut Options Held
5.94M-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.65MShares$49.8 Million0.07% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...